Campbell & Co Investment Adviser’s Transmedics TMDX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,231	Closed	-$1.6M	–	1406
2025 Q3	$1.6M	Buy	+14,231	New	+$1.67M	0.12%	255
2025 Q2	–	Sell	-3,040	Closed	-$205K	–	1468
2025 Q1	$205K	Buy	+3,040	New	+$209K	0.02%	940
2024 Q4	–	Sell	-6,802	Closed	-$1.07M	–	1364
2024 Q3	$1.07M	Buy	6,802 +4,985	+274%	+$768K	0.08%	414
2024 Q2	$274K	Buy	+1,817	New	+$218K	0.02%	858
2023 Q3	–	Sell	-5,538	Closed	-$465K	–	1194
2023 Q2	$465K	Buy	+5,538	New	+$424K	0.08%	475

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Campbell & Co Investment Adviser's TMDX Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 14,231 shares — an estimated $1.6M sold.

Campbell & Co Investment Adviser first reported a position in TMDX in Q2 2023 and held it in 5 quarters. The position peaked at $1.6M in Q3 2025. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

Campbell & Co Investment Adviser reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 14,231 Transmedics shares in Q4 2025, an estimated $1.6M.
Campbell & Co Investment Adviser first reported a position in Transmedics in Q2 2023 and held it in 5 quarters.
Campbell & Co Investment Adviser's Transmedics position peaked at $1.6M in Q3 2025.
428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.